Tg.Ac genetically altered mouse: Assay Working Group overview of available data

Toxicologic Pathology

Volumn 29, Issue SUPPL., 2001, Pages 60-80

  Eastin, W C ^a   Mennear, J H ^a   Tennant, R W ^a   Stoll, R E ^a   Branstetter, D G ^a   Bucher, J R ^a   McCullough, B ^a   Binder, R L ^a   Spalding, J W ^a   Mahler, J F ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

26 Weeks; Carcinogenicity; Hemizygous; Homozygous; Papilloma; Ras gene; Short term; Tg.AC mouse; Transgenic mouse

Indexed keywords

CARCINOGEN; CLOFIBRATE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIETHYLSTILBESTROL; ETHINYLESTRADIOL; MELPHALAN; METHAPYRILENE; PHENACETIN; PHENOBARBITAL; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PIRINIXIC ACID; RESERPINE; SULFAMETHOXAZOLE;

ANIMAL MODEL; CANCER RISK; CARCINOGEN TESTING; CARCINOGENESIS; CHEMOSENSITIVITY; CONFERENCE PAPER; GENE MUTATION; GENETIC MANIPULATION; HEMIZYGOSITY; HOMOZYGOSITY; MUTAGENESIS; PAPILLOMA; PRIORITY JOURNAL; RODENT; TRANSGENIC MOUSE;

ANIMAL TESTING ALTERNATIVES; ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; DISEASE MODELS, ANIMAL; FEMALE; GENES, RAS; GENOTYPE; MALE; MICE; MICE, TRANSGENIC; PAPILLOMA; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 10744225196     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/019262301753178483     Document Type: Conference Paper

References (40)

1. Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples
2. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats
3. Optimization of the Tg.AC transgenic mouse model: II: Responses to dermal and oral phenobarbital (pb)
4. Dermal carcinogenicity in transgenic mice: Relative responsiveness of male and female hemizygous and homozygous Tg.AC mice to 12-o-tetradecanoylphorbol 13-acetate (TPA) and benzene
5. Update on National Toxicology Program (NTP) assays with genetically altered or "transgenic" mice
6. Differential expression of cyclophilin isoforms during keratinocytes differentiation
7. Statistical analysis of skin tumor data from Tg.AC mouse bioassays
8. The National Toxicology Program evaluation of transgenic mice as predictive models for identifying carcinogens
9. The National Toxicology Program evaluation of genetically altered mice as predictive models for identifying carcinogens
10. Chapter 14. Transgenic animals as predictive models for identifying carcinogens
11. Topical application of benzene to Tg.AC (v-Ha-ras) transgenic mice induces skin tumors and leukemia
12. Statistical issues in interpretation of chronic bioassay tests for carcinogencity
13. Cyclosporine induces cancer progression by a cell-automonous mechanism
14. Oxymetholone: II. Evaluation in the Tg.AC transgenic mouse model for detection of carcinogens
15. Decreased mRNA levels of retinoic acid receptor alpha, and thyroid hormone receptor alpha in lesional psoriatic skin
16. Stimulation of PPAR? promotes epidermal keratinocyte differentiation in vivo
17. Assay of peroxisomal ?-oxidation of fatty acids
18. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid
19. Spontaneous and chemically induced proliferative lesions in Tg.AC transgenic and p53-heterozygous mice
20. A preliminary evaluation of the performance of the Muta Mouse™ and Big Blue™ (Iacl) transgenic mouse mutation assays
21. Estradiol arrests hair growth and promotes tumors in mouse skin
22. Cyclosporin inhibits intercellular adhesion molecule-1 expression and reduces mast cell numbers in the asebia mouse model of chronic skin inflammation
23. Testing for increased carcinogenicity using a survival-adjusted quantal response test
24. Time course comparison of cell-cycle protein expression following partial hepatectomy and WY14,643-induced hepatic cell proliferation in F344 rats
25. Strain differences and solvent effects in mouse skin carcinogenesis experiments using carcinogens, tumor initiators and promoters
26. A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase
27. Development of a transgenic mouse model for carcinogenesis bioassays: Evaluation of chemically induced skin tumors in Tg.AC mice
28. Chemically induced skin carcinogenesis in a transgenic mouse line (Tg.AC) carrying a v-Ha-ras gene
29. Examination of genotoxicity, toxicity and morphologic alterations in hepatocytes following in vivo or in vitro exposure to methapyrilene
30. Cancer hazard identification: Toward simplification and interpretability
31. Oxymetholone: III Evaluation in the p53 +/- transgenic mouse model
32. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models
33. Genetically altered mouse models for identifying carcinogens
34. An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. II. A genotypic marker that predicts tumorigenic responsiveness
35. Effects of cyclosporin A, FK 506 and steroid hormones on hair growth
36. Transdermal delivery of cyclosporinA using electroporation
37. Micronucleated erythrocyte frequency in peripheral blood of B6C3F(1) mice from short- term, prechronic, and chronic studies of the NTP carcinogenesis bioassay program
38. Molecular mechanisms of estrogen carcinogenesis
39. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice